Literature DB >> 22409427

Identification of exosite residues of factor Xa involved in recognition of PAR-2 on endothelial cells.

Chandrashekhara Manithody1, Likui Yang, Alireza R Rezaie.   

Abstract

Recent results have indicated that factor Xa (FXa) cleaves protease-activated receptor 2 (PAR-2) to elicit protective intracellular signaling responses in endothelial cells. In this study, we investigated the molecular determinants of the specificity of FXa interaction with PAR-2 by monitoring the cleavage of PAR-2 by FXa in endothelial cells transiently transfected with a PAR-2 cleavage reporter construct in which the extracellular domain of the receptor was fused to cDNA encoding for alkaline phosphatase. Comparison of the cleavage efficiency of PAR-2 by a series of FXa mutants containing mutations in different surface loops indicated that the acidic residues of 39-loop (Glu-36, Glu-37, and Glu-39) and the basic residues of 60-loop (Lys-62 and Arg-63), 148-loop (Arg-143, Arg-150, and Arg-154), and 162-helix (Arg-165 and Lys-169) contribute to the specificity of receptor recognition by FXa on endothelial cells. This was evidenced by significantly reduced activity of mutants toward PAR-2 expressed on transfected cells. The extent of loss in the PAR-2 cleavage activity of FXa mutants correlated with the extent of loss in their PAR-2-dependent intracellular signaling activity. Further characterization of FXa mutants indicated that, with the exception of basic residues of 162-helix, which play a role in the recognition specificity of the prothrombinase complex, none of the surface loop residues under study makes a significant contribution to the activity of FXa in the prothrombinase complex. These results provide new insight into mechanisms through which FXa specifically interacts with its macromolecular substrates in the clotting and signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409427      PMCID: PMC3314109          DOI: 10.1021/bi300200p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  48 in total

1.  Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.

Authors:  Lin Chen; Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

Review 2.  Cofactor proteins in the assembly and expression of blood clotting enzyme complexes.

Authors:  K G Mann; R J Jenny; S Krishnaswamy
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase.

Authors:  M J Weiss; P S Henthorn; M A Lafferty; C Slaughter; M Raducha; H Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

Review 4.  Blood coagulation.

Authors:  C M Jackson; Y Nemerson
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

5.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

6.  Prothrombinase assembly and S1 site occupation restore the catalytic activity of FXa impaired by mutation at the sodium-binding site.

Authors:  Rodney M Camire
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

7.  Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa.

Authors:  Likui Yang; Chandrashekhara Manithody; Steven T Olson; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2003-04-29       Impact factor: 5.157

8.  Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.

Authors:  Alireza R Rezaie; Likui Yang; Chandrashekhara Manithody
Journal:  Biochemistry       Date:  2004-03-16       Impact factor: 3.162

9.  Computer-generated models of blood coagulation factor Xa, factor IXa, and thrombin based upon structural homology with other serine proteases.

Authors:  B Furie; D H Bing; R J Feldmann; D J Robison; J P Burnier; B C Furie
Journal:  J Biol Chem       Date:  1982-04-10       Impact factor: 5.157

10.  The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

Authors:  W Bode; I Mayr; U Baumann; R Huber; S R Stone; J Hofsteenge
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more
  5 in total

Review 1.  Protease-activated receptor signalling by coagulation proteases in endothelial cells.

Authors:  Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

2.  Allosteric regulation of rhomboid intramembrane proteolysis.

Authors:  Elena Arutyunova; Pankaj Panwar; Pauline M Skiba; Nicola Gale; Michelle W Mak; M Joanne Lemieux
Journal:  EMBO J       Date:  2014-07-09       Impact factor: 11.598

3.  Resveratrol inhibits proteinase-activated receptor-2-induced release of soluble vascular endothelial growth factor receptor-1 from human endothelial cells.

Authors:  Bahjat Al-Ani
Journal:  EXCLI J       Date:  2013-07-02       Impact factor: 4.068

4.  Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome.

Authors:  Bahar Artim-Esen; Natalia Smoktunowicz; Thomas McDonnell; Vera M Ripoll; Charis Pericleous; Ian Mackie; Eifion Robinson; David Isenberg; Anisur Rahman; Yiannis Ioannou; Rachel C Chambers; Ian Giles
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

Review 5.  Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment.

Authors:  Hugo Ten Cate; Tomasz J Guzik; John Eikelboom; Henri M H Spronk
Journal:  Cardiovasc Res       Date:  2021-07-27       Impact factor: 10.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.